SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-022301
Filing Date
2014-04-14
Accepted
2014-04-14 08:18:13
Documents
5
Period of Report
2014-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v374667_8k.htm 8-K 20488
2 EXHIBIT 10.1 v374667_ex10-1.htm EX-10.1 71399
3 EXHIBIT 17.1 v374667_ex17-1.htm EX-17.1 2088
4 EXHIBIT 99.1 v374667_ex99-1.htm EX-99.1 9894
5 GRAPHIC tex99-1_logo.jpg GRAPHIC 9839
  Complete submission text file 0001144204-14-022301.txt   118904
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 14761456
SIC: 2834 Pharmaceutical Preparations